Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class ASSE: 605016

"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Establishment of a Wholly-owned Subsidiary in Kunming through External Investment

Sep 10, 2026 · Issued by Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 10, 2026

Announcement on Establishment of a Wholly-owned Subsidiary in Kunming through External Investment

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class A

"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend BriefingAug 31
"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Approval by the Listing Review Committee of the Shanghai Stock Exchange of the Application for Issuance of Convertible Corporate Bonds to Unspecified InvestorsAug 28
"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Indicative Announcement on Revision of the Reply to the Review Inquiry Letter Regarding the Public Offering of Convertible Corporate Bonds to Unspecified InvestorsAug 21
"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Release of Pledge for Part of the Shares and Extension of Pledge of Certain Shares by a Person Acting in Concert with the Controlling ShareholderJul 24

All Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class A news releases